LH
Laboratory Corporation of America Holdings
NYSE: LH · HEALTHCARE · DIAGNOSTICS & RESEARCH
$257.14
-0.94% today
Updated 2026-04-29
Market cap
$21.19B
P/E ratio
24.56
P/S ratio
1.52x
EPS (TTM)
$10.47
Dividend yield
1.11%
52W range
$237 – $292
Volume
0.6M
WallStSmart proprietary scores
63
out of 100
Grade: C+
Hold
Investment rating
6.7
Growth
B6.0
Quality
B5.5
Profitability
C+6.0
Valuation
B4/9
Piotroski F-Score
Moderate
2.3
Altman Z-Score
Grey zone
—
Industry rank
—
View all highly rated stocks (75+) →200 stocks currently score above 75
Price targets
Analyst target
$310.06
+20.58%
12-Month target
$266.52
+3.65%
Intrinsic (DCF)
$314.31
Margin of safety
+7.77%
2 Strong Buy12 Buy5 Hold0 Sell0 Strong Sell
Price chart
X-Ray snapshot
Strengths
+ Free cash flow $490.30M — positive
Risks
No major risks identified
Key financials
Revenue Net Income Free Cash Flow
| Metric | 2022 | 2023 | 2024 | 2025 | TTM | 2026 (E) |
|---|---|---|---|---|---|---|
| Revenue | $11.86B | $12.16B | $13.01B | $13.95B | $13.95B | $15.1B |
| Net income | $1.28B | $418.00M | $746.00M | $876.50M | $164.70M | — |
| EPS | — | — | — | — | $10.47 | $18.42 |
| Free cash flow | $1.47B | $874.10M | $1.10B | $1.21B | $490.30M | — |
| Profit margin | 10.78% | 3.44% | 5.73% | 6.28% | 6.28% | — |
Recent insider activity
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| 2026-03-27 | WILKINSON, PETER J | Sale | 1,633 | $267.05 |
| 2026-03-27 | MELTZER, JONATHAN C | Sale | 839 | $267.05 |
| 2026-03-26 | WILKINSON, PETER J | Buy | 2,388 | — |
Peer comparison
Smart narrative
Laboratory Corporation of America Holdings trades at $257.14. representing a P/E of 24.56x trailing earnings. Our Smart Value Score of 63/100 indicates the stock is good. The company scores 4/9 on the Piotroski F-Score. With an Altman Z-Score of 2.26, it sits in the grey zone. TTM revenue stands at $13.95B. with profit margins at 6.28%. Our DCF model estimates intrinsic value at $314.31.
Frequently asked questions
What is Laboratory Corporation of America Holdings's stock price?
Laboratory Corporation of America Holdings (LH) trades at $257.14.
Is Laboratory Corporation of America Holdings overvalued?
Smart Value Score 63/100 (Grade C+, Hold). DCF value $314.31.
What is the price target of Laboratory Corporation of America Holdings (LH)?
The analyst target price is $310.06, representing +20.6% upside from the current price of $257.14.
What is the intrinsic value of Laboratory Corporation of America Holdings (LH)?
Based on our DCF model, intrinsic value is $314.31, a +7.8% margin of safety versus $257.14.
What is the future stock price of LH by 2030?
Our research-backed model estimates Laboratory Corporation of America Holdings could reach $2,572.97 by 2030, based on analyst consensus, management guidance, and sector analysis.
What is Laboratory Corporation of America Holdings's revenue?
TTM revenue is $13.95B.
Piotroski F-Score?
4/9 — moderate financial health.
Altman Z-Score?
2.26 — grey zone.
Company info
SectorHEALTHCARE
IndustryDIAGNOSTICS & RESEARCH
CountryUSA
ExchangeNYSE
CurrencyUSD
Quick metrics
P/S ratio1.52x
ROE10.50%
Beta0.99
50D MA$271.22
200D MA$268.54
Shares out0.08B
Float0.08B
Short ratio—
Avg volume0.6M
Performance
1 week-2.52%
1 month-5.72%
3 months-5.30%
YTD+2.50%
1 year—
3 years—
5 years—